Status; Epilepticus, Tonic-clonic Clinical Trial
Official title:
Efficiency of Levetiracetam Intravenous in Association With Clonazepam Versus Clonazepam Alone in Prehospital Care of Generalised Tonicoclonic Status Epilepticus
Compare the efficiency of the association, first line, the intravenous levetiracetam and the intravenous clonazepam, in that of a monotherapy of clonazepam intravenous in the pre-hospital treatment of tonicoclonic generalised status epilepticus.
At this time, the prehospital treatment of the status epilepticus use some molecule
("FOSPHENYLOINE") with large contra-indications. In this case the physician is not able to
know the past medical history of the patient, the biological examinations and so he can not
decide which molecules he can use.
The levetiracetam is a knowledge medication in the epilepsy since more than twenty years.
One of specificity of the levetiracetam is to be able to be used in all situations (no
clinical or biological contre-indication). This molecule seems like to be very interesting
to be used in prehospital system.
The goal of this study is to evaluate the association levetiracetam / clonazepam in first
line in the prehospital treatment of the status epilepticus
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment